My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Navidea Biopharmaceuticals, Inc. Common Stock (NY:NAVB)

N/A UNCHANGED

Last Price Updated: 8:00 PM EDT, Oct 5, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Navidea Biopharmaceuticals, Inc. Common Stock

< Previous 1 2 3 Next >

Recap: Navidea Biopharmaceutical Q4 Earnings ↗

March 23, 2022

Navidea Biopharmaceutical (AMEX:NAVB) reported its Q4 earnings results on Wednesday, March 23, 2022 at 07:30 AM. Here's what investors need to know about the...

Via Benzinga

The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale ↗

March 23, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Earnings Outlook For Navidea Biopharmaceutical ↗

March 22, 2022

Navidea Biopharmaceutical (AMEX:NAVB) is set to give its latest quarterly earnings report on Wednesday, 2022-03-23. Here's what investors need to know before the announcement....

Via Benzinga

The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings ↗

March 20, 2022

Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 04, 2022

On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Earnings Scheduled For March 23, 2022 ↗

March 23, 2022

Companies Reporting Before The Bell • AYRO (NASDAQ:AYRO) is expected to report earnings for its fourth quarter. • First Trust NASDAQ Clean Edge Smart Grid...

Via Benzinga

Navidea Shares Jump On Research Pact For Tc99m Tilmanocept As Biomarker In Brain Cancer ↗

February 07, 2022

Navidea Biopharmaceuticals Inc (NYSE: NAVB) has

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 04, 2022

Good morning, trader! It's time to kick off another day with a dive into the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

Earnings Scheduled For May 11, 2021 ↗

May 11, 2021

Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is...

Via Benzinga

47 Biggest Movers From Yesterday ↗

February 08, 2022

Gainers Nuvectis Pharma, Inc. (NASDAQ: NVCT) shares surged 144.6% to close at $7.95 on Monday. The company, on Friday, priced its IPO at $5 per share. Anghami Inc. (NASDAQ: ANGH...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

December 22, 2021

We've reached the halfway point of the week and we're starting it with an overview of the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx ↗

December 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral...

Via Benzinga

Navidea Shares Gain After Terminating Stock Purchase Agreement ↗

December 16, 2021

Navidea Biopharmaceuticals Inc (NYSE: NAVB) has terminated the Stock Purchase Agreement executed on August 30, 2020. The investors agreed to purchase up to $25.0...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 16, 2021

Good morning, trader! We're getting right into the swing of things with a breakdown of the biggest pre-market stock movers for Thursday!

Via InvestorPlace

18 Stocks Moving in Thursday's Pre-Market Session ↗

December 16, 2021

Gainers Calliditas Therapeutics AB (NASDAQ: CALT) rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO...

Via Benzinga

The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance ↗

November 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...

Via Benzinga

Wall Street Crime and Punishment: Martin Shkreli, The Self-Destructive Pharma Bro ↗

November 05, 2021

Does crime pay? Wall Street Crime and Punishment is a weekly series by Benzinga's Phil Hall chronicling the bankers, brokers and financial ne’er-do-wells whose ambition...

Via Benzinga

Looking Into Navidea Biopharmaceutical's Return On Capital Employed ↗

September 28, 2021

According to Benzinga Pro data, during Q2, Navidea Biopharmaceutical (AMEX:NAVB) posted sales of $261.05 thousand. Earnings were up 19.83%, but Navidea Biopharmaceutical still...

Via Benzinga

4 Penny Stocks Insiders Are Buying ↗

September 20, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...

Via Benzinga

Earnings Scheduled For August 11, 2021 ↗

August 11, 2021

Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter. • Gamida Cell (NASDAQ:GMDA) is...

Via Benzinga

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering ↗

August 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...

Via Benzinga

Navidea Stock Gains After FDA Grants End Of Phase 2 Meeting To Discuss Rheumatoid Arthritis Program ↗

July 15, 2021

The FDA has granted Navidea Biopharmaceuticals Inc's (NYSE: NAVB) request for an End-of-Phase 2 Type B meeting to discuss its ongoing program in...

Via Benzinga

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings ↗

May 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...

Via Benzinga

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.